Arsani William - 28 Aug 2023 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role
Director
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol
DSGN
Transactions as of
28 Aug 2023
Transactions value $
$5,373,650
Form type
4
Filing time
30 Aug 2023, 19:02:07 UTC
Previous filing
02 Jun 2023
Next filing
17 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DSGN Common Stock Purchase $591,250 +275,000 +35.95% $2.15 1,040,000 28 Aug 2023 By Logos Global Master Fund LP F1, F2
transaction DSGN Common Stock Purchase $4,782,400 +1,960,000 +1.88% $2.44 3,000,000 29 Aug 2023 By Logos Global Master Fund LP F2, F3
holding DSGN Common Stock 1,217,627 28 Aug 2023 By Logos Opportunities Fund II, L.P. F4
holding DSGN Common Stock 814,874 28 Aug 2023 By Logos SPV 1 LP F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction was $2.15. The shares were purchased at a range of prices between $2.11 and $2.1677, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F2 Logos GP LLC ("Fund GP") is the general partner of Logos Global Master Fund LP (the "Fund"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 The weighted average purchase price for the transaction was $2.44. The shares were purchased at a range of prices between $2.29 and $2.50, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F4 Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP ("LOF II") and Logos SPV 1 LP ("SPV 1"). Logos Opportunities GP LLC ("GP I") is the general partner of LOF II. Logos Opportunities II GP LLC ("GP II") is the general partner of SPV 1. The Reporting Person is the Managing Member of both GP I and GP II. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.